Wednesday - July 22, 2026
FDA Issues Warning Letter to Center For Immunology Science
January 28, 2026
WASHINGTON, Jan. 28 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Center For Immunology Science LLC from the Center for Drug Evaluation and Research:

* * *

Recipient: Bruce S. Gillis, M.D., MPH, CEO, Center For Immunology Science, LLC, 2109 Granville Avenue, Los Angeles, CA 90025-6105, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products